 |
|
|
| |
Reyataz Induction/Maintenance From Boosted to Unboosted: Similar Efficacy and Tolerability of Atazanavir (ATV) Compared to Atazanavir/Ritonavir (ATV/r), each with Abacavir/Lamivudine (ABC/3TC) after Initial Suppression with ABC/3TC + ATV/r: 84 Week Results of the ARIES Trial
|
| |
| |
Reported by Jules Levin
IAS Capetown July 22 2009
Kathleen Squires, MD
Professor of Medicine, Thomas Jefferson University
Philadelphia, PA
|
| |
|
|
|
|
|
